Manufacturer
Eisai
Pharmaceutical manufacturer based in Japan
Japan
- Products listed
- 23
- Molecules
- 7
- Therapy areas
- 3
Eisai is a pharmaceutical manufacturer based in Japan. MedsAcross lists 23 of its products across 7 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- Japan
- Indian manufacturer
- No
- Also listed as
- Eisai GmbH, Eisai Inc.
- EU marketing authorisation holder
- YesSource: European Medicines Agency
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Eisai products through licensed channels, with the documents your regulator needs.
Neurology
10 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Banzel 200 mg tabletOral | Rufinamide | US FDA | Available on request |
| Banzel 40 mg/mL oral suspensionOral | Rufinamide | US FDA | Available on request |
| Banzel 400 mg tabletOral | Rufinamide | US FDA | Available on request |
| Fycompa 0.5 mg/mL oral suspensionOral | Perampanel | US FDA | Available on request |
| Fycompa 10 mg tabletOral | Perampanel | US FDA | Available on request |
| Fycompa 12 mg tabletOral | Perampanel | US FDA | Available on request |
| Fycompa 2 mg tabletOral | Perampanel | US FDA | Available on request |
| Fycompa 4 mg tabletOral | Perampanel | US FDA | Available on request |
| Fycompa 6 mg tabletOral | Perampanel | US FDA | Available on request |
| Fycompa 8 mg tabletOral | Perampanel | US FDA | Available on request |
Psychiatry
7 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Aricept 10 mg tabletOral | Donepezil | US FDA | Available on request |
| Aricept 23 mg tabletOral | Donepezil | US FDA | Available on request |
| Aricept 5 mg tabletOral | Donepezil | US FDA | Available on request |
| Lecanemab Autoinjector 250 mg/1.25 mL injectionSubcutaneous Cold chain | Lecanemab | US FDA | Available on request |
| Lecanemab Autoinjector 360 mg/1.8 mL injectionSubcutaneous Cold chain | Lecanemab | US FDA | Available on request |
| Leqembi 200 mg/2 mL injectionIntravenous Cold chain | Lecanemab | US FDA | Available on request |
| Leqembi 500 mg/5 mL injectionIntravenous Cold chain | Lecanemab | US FDA | Available on request |
Oncology
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Halaven 1 mg/2 mL injectionIntravenous | Eribulin | US FDA | Available on request |
| Lenvima kit | Lenvatinib | US FDA | Available on request |
| Lenvima 10 mg capsuleOral | Lenvatinib | US FDA | Available on request |
| Lenvima 4 mg capsuleOral | Lenvatinib | US FDA | Available on request |
Other products
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Dayvigo 10 mg tabletOral | Lemborexant | US FDA | Available on request |
| Dayvigo 5 mg tabletOral | Lemborexant | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Eisai
Send a request for any of these products. We confirm the licensed source, documents and lead time.